Detailed Information on Publication Record
2020
12-O-Tetradecanoylphor bol-13-acetate increases cardiomyogenesis through PKC/ERK signaling
RADASZKIEWICZ, Katarzyna Anna, Deborah BECKEROVÁ, Lucie WOLOSZCZUKOVÁ, Tomasz Witold RADASZKIEWICZ, Petra LESÁKOVÁ et. al.Basic information
Original name
12-O-Tetradecanoylphor bol-13-acetate increases cardiomyogenesis through PKC/ERK signaling
Authors
RADASZKIEWICZ, Katarzyna Anna (616 Poland, belonging to the institution), Deborah BECKEROVÁ (203 Czech Republic, belonging to the institution), Lucie WOLOSZCZUKOVÁ (203 Czech Republic, belonging to the institution), Tomasz Witold RADASZKIEWICZ (616 Poland, belonging to the institution), Petra LESÁKOVÁ (203 Czech Republic, belonging to the institution), Olga VONDÁLOVÁ BLANÁŘOVÁ (203 Czech Republic, belonging to the institution), Lukáš KUBALA (203 Czech Republic, belonging to the institution), Petr HUMPOLÍČEK and Jiří PACHERNÍK (203 Czech Republic, guarantor, belonging to the institution)
Edition
Scientific reports, Berlin, Nature Research, 2020, 2045-2322
Other information
Language
English
Type of outcome
Článek v odborném periodiku
Field of Study
10601 Cell biology
Country of publisher
Germany
Confidentiality degree
není předmětem státního či obchodního tajemství
References:
Impact factor
Impact factor: 4.379
RIV identification code
RIV/00216224:14310/20:00114532
Organization unit
Faculty of Science
UT WoS
000577348000016
Keywords in English
Cell biology; Developmental biology; Stem cells
Tags
Tags
International impact, Reviewed
Změněno: 4/3/2021 12:34, Mgr. Tereza Miškechová
Abstract
V originále
12-O-Tetradecanoylphorbol-13-acetate (TPA) is the most widely used diacylglycerol (DAG) mimetic agent and inducer of protein kinase C (PKC)-mediated cellular response in biomedical studies. TPA has been proposed as a pluripotent cell differentiation factor, but results obtained have been inconsistent. In the present study we show that TPA can be applied as a cardiomyogenesis-promoting factor for the differentiation of mouse embryonic stem (mES) cells in vitro. The mechanism of TPA action is mediated by the induction of extracellular signal-regulated kinase (ERK) activity and the subsequent phosphorylation of GATA4 transcription factor. Interestingly, general mitogens (FGF, EGF, VEGF and serum) or canonical WNT signalling did not mimic the effect of TPA. Moreover, on the basis of our results, we postulate that a TPA-sensitive population of cardiac progenitor cells exists at a certain time point (after days 6-8 of the differentiation protocol) and that the proposed treatment can be used to increase the multiplication of ES cell-derived cardiomyocytes.
Links
GA18-18235S, research and development project |
| ||
MUNI/A/0951/2019, interní kód MU |
| ||
MUNI/A/1145/2017, interní kód MU |
|